Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD3 | P35462 | 11/20 | 0.53 |
| ▸ | DRD2 | P14416 | 9/20 | 0.53 |
| ▸ | HTR7 | P34969 | 3/20 | 0.53 |
| ▸ | DRD5 | P21918 | 1/20 | 0.53 |
| ▸ | DRD1 | P21728 | 4/20 | 0.52 |
| ▸ | HTR1A | P08908 | 2/20 | 0.51 |
| ▸ | HTR2A | P28223 | 1/20 | 0.51 |
| ▸ | DRD4 | P21917 | 2/20 | 0.50 |
| ▸ | FAAH | O00519 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17898235 | 0.94 | DRD3 (0.61) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13448986 | 0.87 | DRD2 (0.57) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13448990 | 0.87 | DRD3 (0.65) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL2027865 | 0.86 | DRD3 (0.70) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL17898231 | 0.82 | DRD3 (0.60) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13448963 | 0.81 | DRD3 (0.58) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL27344744 | 0.81 | DRD2 (0.58) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13448967 | 0.81 | DRD3 (0.80) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13449000 | 0.81 | DRD3 (0.77) | DRD3DRD2HTR7DRD5DRD1 | |
| SCHEMBL13448975 | 0.80 | DRD3 (0.79) | DRD3DRD2HTR7DRD5DRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160196412-A1 | DESIGN OF MOLECULES | RECURSION PHARMACEUTICALS, INC. | 2016-07-07 | — | — | US | disclosed |
| US-20160196412-A1 | DESIGN OF MOLECULES | RECURSION PHARMACEUTICALS, INC. | 2016-07-07 | — | — | US | disclosed |